You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: RE36418


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: RE36418
Title: Contrast media comprising a non-ionic contrast agent with low levels of sodium and calcium ions
Abstract:The physiological acceptability of contrast media, especially media for use in angiography, may be enhanced by inclusion of sub-plasma levels of sodium and calcium and, optionally, potassium and/or magnesium, for example 30 mM Na, 0.15 mM Ca, 0.9 mM K and 0.1 mM Mg.
Inventor(s): Almen; Torsten (Malmo, SE), Baath; Lars (Malmo, SE), Jynge; Per (Trondheim, NO), Oksendal; Audun Nesheim (Oslo, NO)
Assignee: Nycomed Imaging AS (Oslo, NO)
Application Number:08/616,245
Patent Claim Types:
see list of patent claims
Composition;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of U.S. Patents: A Detailed Analysis

Introduction

When navigating the complex world of patents, understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the key aspects of patent scope, claims, and the broader patent landscape, using the U.S. Patent RE36418 as a case study.

What are Patent Claims?

Patent claims are the legal definitions of what the inventor considers to be their invention. They define the scope of protection granted by the patent and are a critical component of the patent application process[3].

Types of Patent Claims

There are two main types of patent claims: independent and dependent claims.

  • Independent Claims: These claims stand alone and define the invention without reference to other claims. They are typically broader and more comprehensive[3].
  • Dependent Claims: These claims refer back to and further limit an independent claim. They are narrower and often provide additional details or specific embodiments of the invention.

Measuring Patent Scope

The scope of a patent is often debated in terms of its breadth and clarity. Two simple metrics used to measure patent scope are independent claim length and independent claim count.

  • Independent Claim Length: Longer claims often indicate broader and more complex inventions. However, during the examination process, claims tend to narrow, resulting in shorter, more specific claims[3].
  • Independent Claim Count: The number of independent claims can also indicate the breadth of the patent. Fewer independent claims may suggest a more focused invention, while multiple claims could indicate a broader scope.

The Examination Process and Patent Scope

The patent examination process significantly influences the final scope of a patent. Here are some key points:

  • Narrowing of Claims: The examination process tends to narrow the scope of patent claims. This is because examiners often require applicants to clarify and limit their claims to ensure they are novel and non-obvious[3].
  • Continuation Procedures: Continuation procedures, such as Requests for Continued Examination (RCEs) and continuation-in-part (CIP) applications, can affect the scope. These procedures allow applicants to refine their claims, potentially leading to narrower but more secure patents[1].

U.S. Patent RE36418: A Case Study

To illustrate these concepts, let's consider U.S. Patent RE36418, though specific details of this patent are not provided here. Here’s how the general principles apply:

  • Claim Structure: Analyze the independent and dependent claims to understand the core invention and its various embodiments.
  • Scope: Determine the breadth of the patent by examining the length and count of independent claims. This will help in understanding the protection granted.
  • Examination History: Review the prosecution history to see how the claims were narrowed or modified during the examination process. This can be done using tools like the Patent Public Search or the Patent Examination Data System (PEDS)[4].

Patent Allowance Rates

Understanding the probability of receiving a patent is crucial. The USPTO tracks several allowance rates:

  • First-Action Allowance Rate: The proportion of applications allowed without further examination.
  • Progenitor Allowance Rate: The proportion of applications allowed without any continuation procedure.
  • Family Allowance Rate: The proportion of applications that produce at least one patent, including outcomes of continuation applications[1].

The Role of Continuation Procedures

Continuation procedures are common in patent applications and can significantly impact the scope and claims.

  • Non-Serialized Continuations: These include RCEs, which allow applicants to continue the examination process without abandoning the original application[1].
  • Serialized Continuations: These include divisional applications and continuations-in-part, which can introduce new subject matter and result in multiple patents from a single progenitor application[1].

Global Patent Landscape

The patent landscape extends beyond the U.S., with international offices and databases playing a crucial role.

  • Global Dossier: This service provides access to file histories of related applications from participating IP offices, helping in cross-border patent research[4].
  • International Patent Databases: Databases from the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO) offer comprehensive search capabilities for global patent research[4].

Tools for Patent Search and Analysis

Several tools are available for searching and analyzing patents:

  • Patent Public Search: A modern web-based search application that replaced legacy tools like PubEast and PubWest[4].
  • Global Dossier: Provides access to related applications from participating IP offices[4].
  • Patent Examination Data System (PEDS): Allows public users to search, view, and download bibliographic data for patent applications[4].

Legal and Policy Considerations

The legal and policy framework surrounding patents is evolving.

  • Small Claims Patent Court: There have been studies and discussions on establishing a small claims patent court to address issues related to patent litigation costs and accessibility[2].
  • Enablement Guidelines: The USPTO issues guidelines on assessing enablement in utility applications, reflecting changes in legal interpretations and Supreme Court decisions[5].

Key Takeaways

  • Patent Claims: Define the scope of protection and are critical in the patent application process.
  • Patent Scope: Measured by claim length and count, and often narrowed during the examination process.
  • Continuation Procedures: Impact the scope and claims, allowing for refinement and additional protection.
  • Global Landscape: International databases and tools are essential for comprehensive patent research.
  • Legal Framework: Evolving guidelines and potential reforms, such as a small claims patent court, can affect patent strategies.

FAQs

What is the purpose of patent claims?

Patent claims legally define the invention and the scope of protection granted by the patent.

How does the examination process affect patent scope?

The examination process tends to narrow the scope of patent claims to ensure they are novel and non-obvious.

What are continuation procedures in patent applications?

Continuation procedures, such as RCEs and CIPs, allow applicants to refine their claims and continue the examination process without abandoning the original application.

How can I search for patents globally?

Global patent search can be conducted using databases from the EPO, JPO, WIPO, and other international IP offices, as well as tools like Global Dossier and Patent Public Search.

What is the significance of the first-action allowance rate?

The first-action allowance rate indicates the proportion of applications allowed without further examination, providing insight into the efficiency of the patent examination process.

Sources

  1. Carley, M., & Hegde, D. (n.d.). What Is the Probability of Receiving a US Patent?. The Yale Journal of Law & Technology.
  2. Administrative Conference of the United States. (n.d.). U.S. Patent Small Claims Court. ACUS.
  3. Helmers, C., & Love, B. J. (2016). Patent Claims and Patent Scope. SSRN.
  4. United States Patent and Trademark Office. (n.d.). Search for patents. USPTO.
  5. United States Patent and Trademark Office. (2024). Guidelines for Assessing Enablement in Utility Applications and Reexamination Proceedings. Federal Register.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent RE36418

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: RE36418

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
90 200580Mar 09, 1990
United Kingdom90 20091Sep 14, 1990

International Family Members for US Patent RE36418

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 141519 ⤷  Subscribe
Australia 645544 ⤷  Subscribe
Australia 7345191 ⤷  Subscribe
Canada 2076861 ⤷  Subscribe
China 1055864 ⤷  Subscribe
China 1056058 ⤷  Subscribe
Czechoslovakia 9100619 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.